Nutrien Ltd NTR.TO is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The Saskatoon Saskatchewan-based company is expected to report a 6.1% increase in revenue to $10.521 billion from $9.92 billion a year ago, according to the mean estimate from 9 analysts, based on LSEG data. (Sales is on Net Revenue excluding Freight)
LSEG's mean analyst estimate for Nutrien Ltd is for earnings of $2.43 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 9 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Nutrien Ltd is $65.00, about 9.9% above its last closing price of $58.56
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | 0.29 | 0.31 | 0.11 | Missed | -64.3 |
Dec. 31 2025 | 0.33 | 0.35 | 0.31 | Missed | -12.1 |
Sep. 30 2024 | 0.45 | 0.45 | 0.39 | Missed | -13.9 |
Jun. 30 2024 | 2.18 | 2.19 | 2.34 | Beat | 6.8 |
Mar. 31 2024 | 0.35 | 0.37 | 0.46 | Beat | 24.3 |
Dec. 31 2023 | 0.63 | 0.65 | 0.37 | Missed | -43.5 |
Sep. 30 2023 | 0.64 | 0.66 | 0.35 | Missed | -46.8 |
Jun. 30 2023 | 2.77 | 2.79 | 2.53 | Missed | -9.2 |
This summary was machine generated August 4 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。